Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
US5849710A · kind A · utility
27Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 1996 |
| Grant date | Dec 15, 1998 |
| Priority date | — |
| Expiry date | Dec 4, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to indol-3-ylmethylene-2-oxindole derivatives which are useful as tyrosine kinase inhibitors. The compounds are suitable for use as anti-proliferative agents, anti-metastatic agents, anti-cancer agents, and in the control of angiogenesis and in inhibiting the development of atheromatous and an immunomogulating agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.